Tuesday October 24, 2017 00:17

Heathcare Press Release : 08 Aug 2017

NICE Recommends Erbitux(R) in Combination with Platinum-Based Chemotherapy for the Treatment of Heathcare—08 Aug 17

- Decision secures access to Erbitux(R) for new patients in England with oral cavity tumors - All patients currently receiving Erbitux(R) will have continued access Merck, a leading science and technology company, announced today that the National